1-2 of 2
Pascual Fernández-Abellan
Close
Sort by
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Miguel-Angel Sanz, Pau Montesinos, Josep Sarra, Salut Brunet, Pascual Fernández-Abellan, Ramon Guardia, Jordi Esteve, Jose Gonzalez-Campos, Arancha Bermudez, Maria-Jose Moreno, Maria-Teresa Bernal, Mar Tormo, Eloy Del Potro, Antonia Cladera, Andreu Llorente, Raimundo Garcia-Boyero, Maria-Jose Rabuñal, Juan Bergua, Carlos Grande, Maria-Luz Amigo, Javier Bueno, Concepcion Bethencourt, Jesus-Maria Hernandez-Rivas, Evarist Feliu
Journal: Blood
Blood (2009) 114 (22): 322.
https://doi.org/10.1182/blood.V114.22.322.322
Published: 2009
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Josep Sarra, Pau Montesinos, Salut Brunet, Ramon Guardia, Pascual Fernández-Abellan, Teresa Bernal, MD, Arancha Bermudez, Maria-Jose Moreno, Ricardo Parody, Mar Tormo, Eloy Del Potro, Andreu Llorente, Raimundo Garcia-Boyero, Jordi Esteve, Maria-Jose Rabuñal, Emilia Pardal, Carlos Grande, Javier Bueno, Antonia Cladera, Concepcion Bethencourt, Victoria Martin-Reina, Maria-Luz Amigo, Jesus-Maria Hernandez-Rivas, Miguel-Angel Sanz, Evarist Feliu
Journal: Blood
Blood (2008) 112 (11): 3291.
https://doi.org/10.1182/blood.V112.11.3291.3291
Published: 2008